Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is a risk factor for colorectal cancer (CRC). We evaluated chemotherapy tolerance and oncologic outcomes from the medical records of patients with CRC with and without IBD. In this series, patients with CRC with IBD experienced more treatment alterations than those w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Colorectal Cancer
Autors principals: Axelrad, Jordan, Kriplani, Anuja, Ozbek, Umut, Harpaz, Noam, Colombel, Jean-Frederic, Itzkowitz, Steven, Holcombe, Randall F., Ang, Celina
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6009836/
https://ncbi.nlm.nih.gov/pubmed/27742264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2016.09.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars